| A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats A Durak, Y Olgar, S Degirmenci, E Akkus, E Tuncay, B Turan Cardiovascular diabetology 17, 1-17, 2018 | 144 | 2018 |
| Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer N Pällmann, M Livgård, M Tesikova, H Zeynep Nenseth, E Akkus, ... Oncogene 38 (35), 6301-6318, 2019 | 64 | 2019 |
| Glucagon‐like peptide‐1 receptor agonist treatment of high carbohydrate intake‐induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through … A Durak, E Akkus, AG Canpolat, E Tuncay, D Corapcioglu, B Turan Clinical and Experimental Pharmacology and Physiology 49 (1), 46-59, 2022 | 14 | 2022 |
| Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation PA Atilla, E Akkus, E Atilla, N Gokmen, SC Bozdag, SK Toprak, MK Yuksel, ... Transfusion Clinique et Biologique 27 (3), 115-121, 2020 | 12 | 2020 |
| Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group M Gürbüz, Y Kutlu, E Akkuş, EB Köksoy, N Köse, BB Öven, BO Uluç, ... Journal of cancer research and clinical oncology 148 (12), 3547-3555, 2022 | 8 | 2022 |
| Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantation P Ataca Atilla, E Akkus, E Atilla, N Gokmen, S Civriz Bozdag, ... Clinical Transplantation 34 (10), e14049, 2020 | 8 | 2020 |
| Topical aloe vera for the treatment of cetuximab-related acneiform rash in colorectal cancer: a case report M Gürbüz, E Akkuş, G Utkan Journal of Oncology Pharmacy Practice 27 (2), 480-484, 2021 | 7 | 2021 |
| Sweet’s syndrome under ipilimumab therapy and a brief comparison of the cases in literature HA Yaşar, E Akkus, A Heper, BN Akay, Y Urun, G Utkan Journal of Oncology Pharmacy Practice 26 (7), 1762-1764, 2020 | 7 | 2020 |
| Mean platelet volume and response to the first line therapy in newly diagnosed adultimmune thrombocytopenia patients: a retrospective study E Akkuş, Ç Fidan, G Demirci, AA Kuştaş, M Yüksel Turkish Journal of Medical Sciences 50 (4), 798-803, 2020 | 7 | 2020 |
| Fibroblast function in COVID-19 M Sahin, E Akkus Pathology, Research and Practice 219, 153353, 2021 | 6 | 2021 |
| Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer M Gürbüz, E Akkuş, A Sakin, S Urvay, AG Demiray, S Şahin, T Şakalar, ... Tumori Journal 107 (5), 416-423, 2021 | 5 | 2021 |
| Related molecular mechanisms of COVID-19, hypertension, and diabetes E Akkus, M Sahin American Journal of Physiology-Endocrinology and Metabolism 318 (6), E881-E881, 2020 | 5 | 2020 |
| Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: retrospective real‐life data M Gürbüz, İ Doğan, E Akkuş, H Ermiş, G Utkan, S Vatansever, F Taş Dermatologic therapy 34 (6), e15122, 2021 | 4 | 2021 |
| Asymptomatic pyuria and bacteriuria are not risk factors for urinary tract infection in women with type 2 diabetes mellitus initiated SGLT2 inhibitors E Akkuş, A Gökçay Canpolat, Ö Demir, D Çorapçıoğlu, M Şahin International Urology and Nephrology 56 (3), 1165-1172, 2024 | 3 | 2024 |
| Clinical evaluation of DIAGNOVIR SARS-CoV-2 ultra-rapid antigen test performance compared to PCR-based testing AA Seymen, E Gulten, E Ozgur, B Ortaç, I Akdemir, G Cinar, ... Scientific Reports 13 (1), 4438, 2023 | 3 | 2023 |
| Trastuzumab±capecitabine maintenance after the first-line treatment of HER2-positive advanced gastric cancer: retrospective observational real-life data of Turkish Oncology Group M Gürbüz, E Akkuş, A Sakin, S Urvay, AG Demiray, S Şahin, T Şakalar, ... Journal of Gastrointestinal Cancer 53 (2), 282-288, 2022 | 3 | 2022 |
| Trastuzumab+/-Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group M Gurbuz, E Akkus, A Sakin, S Urvay, A Demiray, S Sahin, T Sakalar, ... JOURNAL OF GASTROINTESTINAL CANCER 53 (2), 2022 | 2 | 2022 |
| Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group M Gürbüz, S Kiliçkap, A Bilici, N Karadurmuş, A Sezer, MAN Şendur, ... Medicine 101 (50), e32368, 2022 | 1 | 2022 |
| Comment on “Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management” M Sahin, E Akkus Journal of Translational Internal Medicine 8 (3), 199-199, 2020 | 1 | 2020 |
| Impact of ABO mismatch on outcomes of allogeneic hematopoietic stem cell recipients: 30 years of experience with 1016 patients E Atilla, P Topcuoglu, E Akkus, PA Atilla, SC Bozdag, MK Yuksel, ... Blood 132, 3472, 2018 | 1 | 2018 |
